TBPH
Theravance Biopharma, Inc.16.88post−$0.00 (−0.03%)at close +$0.01 (+0.06%)
as of 19:59:58 UTCnext report Aug 10 · 5d
Earnings Room‹ back to TBPH
The report
fiscal Q2 2026 · from the company's noticeAug 10after close5days out
Expected movement
market-implied · at the Aug 4 close±13.6%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Aug 21 · first after the reportATM strike 17.5straddle 2.70ATM IV 88%× 0.85 straddle-to-rangespot 16.88
Blast radius
3 linked · N-PORT + EDGARIf TBPH moves ±13.6% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are named by filings and their coefficient measured against two years of daily returns.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color0/8reports moved further than the options market had pricedtypically ±9.4% realized vs ±20.5% priced
May 7 '26±10.3%→+0.5%×0.05
Mar 19 '26±12.0%→+1.3%×0.11
Mar 3 '26±54.3%→−26.3%×0.48
Nov 10 '25±24.6%→+22.7%×0.92
Aug 12 '25±24.8%→+4.2%×0.17
May 8 '25±12.1%→−9.3%×0.77
Feb 26 '25±13.8%→+2.1%×0.15
Nov 12 '24±12.3%→+8.6%×0.70
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.10 · rev $18M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.